References

  1. Knobler S, Mahmoud A, Lemon S, Pray L, eds. The Impact of Globalization on Infectious Disease Emergence and Control. Washington, DC: National Academies Press; 2006.
  2. Heymann D, Rodier G. Global surveillance, national surveillance, and SARS. Emerg Infect Dis 2004;10(2):173–175.
  3. U.S. Government Accounting Office. Emerging Infectious Diseases: Asian SARS Outbreak Challenged International and National Responses. Report No. GAO-04-564. Washington, DC: GAO; April 2004. http://www.gao.gov/new.items/d04564.pdf. Accessed August 8, 2007.
  4. Committee on R&D Needs for Improving Civilian Medical Response to Chemical and Biological Terrorism Incidents, Institute of Medicine. Chemical and Biological Terrorism: Research and Development to Improve Civilian Medical Response. Washington, DC: National Academies Press; 1999.
  5. World Health Assembly. Revision of International Health Regulations. 58th World Health Assembly Documentation. Geneva: World Health Organization; 2005. http://www.who.int/gb/e/e_wha58.html. Accessed August 8, 2007.
  6. International Health Regulations (1969). Geneva: World Health Organization; 1983.
  7. Frequently asked questions about the International Health Regulations. Geneva: World Health Organization. http://www.who.int/csr/ihr/howtheywork/faq/en/print.html. Accessed March 29, 2007.
  8. Baker MG, Fidler DP. Global public health surveillance under new International Health Regulations. Emerg Infect Dis 2006;12(7):1058–1065.
  9. Fidler DP. Germs, governance, and global public health in the wake of SARS. J Clin Invest 2004 Mar;113(6):799–804.
  10. Green M, Kaufman Z. Surveillance for early detection and monitoring of infectious disease outbreaks associated with bioterrorism. Isr Med Assoc J 2002;4(7):503–506.
  11. Lober WB, Karras BT, Wagner MM, et al. Roundtable on bioterrorism detection: information system-based surveillance. J Am Med Inform Assoc 2002 Mar-Apr;9(2):105–115.
  12. Hopkins RS, Shillam P, Gaspard B, Eisnach L, Karlin RJ. Waterborne disease in Colorad three years’ surveillance and 18 outbreaks. Am J Public Health 1985;75(3):254–257.
  13. Mostashari F, Hartman J. Syndromic surveillance: a local perspective [editorial]. J Urban Health 2003;80(suppl 1):i1–i7.
  14. Layne SP. Human influenza surveillance: the demand to expand. Emerg Infect Dis 2006 Apr;12(4):562–568.
  15. Levac S. Biological threat reduction in Central Asia and the Caucasus. Paper presented at: CBW Breakfast Seminar Series; March 28, 2006; Washington, DC.
  16. Hutwagner L, Thompson W, Seeman GM, Treadwell T. The bioterrorism preparedness and response Early Aberration Reporting System (EARS). J Urban Health 2003;80(Suppl 1):i89–i96.
  17. Lombardo J, Burkom H, Elbert E, et al. A systems overview of the Electronic Surveillance System for the Early Notification of Community-Based Epidemics (ESSENCE II). J Urban Health 2003;80(Suppl 1):i32–i42.
  18. Muhm JM, Karras BT. Syndromic surveillance. Aviat Space Environ Med 2003 Mar;74(3):293–294.
  19. Platt R, Bocchino C, Caldwell B, et al. Syndromic surveillance using minimum transfer of identifiable data: the example of the National Bioterrorism Syndromic Surveillance Demonstration Program. J Urban Health 2003;80(Suppl 1):i25–i31.
  20. Begier EM, Sockwell D, Branch LM, et al. The National Capitol Region’s Emergency Department syndromic surveillance system: do chief complaint and discharge diagnosis yield different results? Emerg Infect Dis 2003 Mar;9(3):393–396.
  21. Rodman JS, Frost F, Jakubowski W. Using nurse hot line calls for disease surveillance. Emerg Infect Dis 1998;4(2):329–332.
  22. Wagner M, Moore A, Aryel R, eds. Handbook of Biosurveillance. Los Angeles: Elsevier; 2006.
  23. Cash RA, Narasimhan V. Impediments to global surveillance of infectious diseases: consequences of open reporting in a global economy. Bull World Health Organ 2000;78(11):1358–1367.
  24. Grein TW, Kamara KB, Rodier G, et al. Rumors of disease in the global village: outbreak verification. Emerg Infect Dis 2000 Mar-Apr;6(2):97–102.
  25. Global Outbreak Alert and Response Network (GOARN). World Health Organization website. http://www.who.int/csr/outbreaknetwork/en/. Accessed August 14, 2007.
  26. Heymann DL, Rodier GR, WHO Operational Support Team to the Global Outbreak Alert and Response Network. Hot spots in a wired world: WHO surveillance of emerging and re-emerging infectious diseases. Lancet Infect Dis 2001 Dec;1(5):345–353.
  27. Damon IK, Roth CE, Chowdhary V. Discovery of monkeypox in Sudan. N Engl J Med 2006 Aug 31;355(9):962–963.
  28. Damon I. Monkeypox virus: insights on its emergence in human populations. In: Scheld WM, Hooper DC, Hughes JM, eds. Emerging Infections 7. Washington, DC: ASM Press; 2006:85–97.
  29. Madoff LC, Woodall JP. The internet and the global monitoring of emerging diseases: lessons from the first 10 years of ProMED-mail. Arch Med Res 2005 Nov–Dec;36(6):724–730.
  30. Fan EX. SARS: Economic Impacts and Implications. ERD Policy Brief Series No. 15. Manila, Philippines: Asian Development Bank; 2003. http://www.asiandevbank.org/documents/EDRC/Policy_Briefs/PB015.pdf. Accessed August 8, 2007.
  31. Mykhalovskiy E, Weir L. The Global Public Health Intelligence Network and early warning outbreak detection: a Canadian contribution to global public health. Can J Public Health 2006 Jan–Feb;97(1):42–44.
  32. Morse SS, Rosenberg BH, Woodall J. ProMED global monitoring of emerging diseases: design for a demonstration program. Health Policy 1996 Dec;38(3):135–153.
  33. Madoff LC. ProMED-mail: an early warning system for emerging diseases. Clin Infect Dis 2004 July 15;39(2):227–232.
  34. Woodall JP. Global surveillance of emerging diseases: the ProMED-mail perspective. Cad Saude Publica 2001;17 Suppl:147–154.
  35. Hippisley-Cox J, Smith S, Smith G, et al. QFLU: new influenza monitoring in UK primary care to support pandemic influenza planning. Euro Surveill 2006 June 22;11(6):E060622.4.
  36. Lenglet A, Hernandez Pezzi G. Comparison of the European Union Disease Surveillance Networks’ websites. Euro Surveill 2006;11(5):119–122.
  37. European Influenza Surveillance Scheme. Annual Report: 2004-2005 Influenza Season. Utrecht: EISS; May 2006. http://www.eiss.org/documents/eiss_annual_report_2004-2005_+_cover.pdf. Accessed August 14, 2007.
  38. Kitler ME, Gavinio P, Lavanchy D. Influenza and the work of the World Health Organization. Vaccine 2002 May 15;20 Suppl 2:S5–14.
  39. Stohr K. The global agenda on influenza surveillance and control. Vaccine 2003 May 1;21(16):1744–1748.
  40. de Quadros CA, Andrus JK, Olive JM, Guerra de Macedo C, Henderson DA. Polio eradication from the Western Hemisphere. Annu Rev Public Health 1992;13:239–252.
  41. Robertson SE, Suleiman AJ, Mehta FR, al-Dhahry SH, el-Bualy MS. Poliomyelitis in Oman: acute flaccid paralysis surveillance leading to early detection and rapid response to a type 3 outbreak. Bull World Health Organ 1994;72(6):
    907–914.
  42. Andrus JK, Thapa AB, Withana N, Fitzsimmons JW, Abeykoon P, Aylward B. A new paradigm for international disease control: lessons learned from polio eradication in Southeast Asia. Am J Public Health 2001 Jan;91(1):146–150.
  43. Pan American Health Organization. Regional Strategy for Sustaining National Immunization Programs in the Americas. 47th Directing Council. Washington, DC: PAHO; 2006. http://www.paho.org/English/GOV/CD/CD47-11rv-e.pdf. Accessed August 14, 2007.
  44. Andrus JK, Strebel PM, deQuadros CA, Olivé JM. Estimated risk of vaccine-associated paralytic poliomyelitis in Latin America, 1989-91. Bull World Health Organ 1995;73(1):33–40.
  45. Castillo-Solórzano C, Andrus JK. Rubella elimination and improving health care for women. Emerg Infect Dis 2004 Nov;10(11):2017–2021.
  46. Tambini G, Andrus JK, Fitzsimmons JW, Roses Periago M. Regional immunization programs as a model for strengthening cooperation among nations. Rev Panam Salud Publica 2006 Jul;20(1):54–59.
  47. U.S. Centers for Disease Control and Prevention. Global Disease Detection 2006. Atlanta: CDC; 2006. http://www.cdc.gov/cogh/pdf/GDDGlance0707.pdf. Accessed August 14, 2007.
  48. Statement by James W. LeDuc on avian influenza A (H5N1): update and preparedness actions related to tourism and trade. Committee on Commerce, Science, and Transportation Subcommittee on Trade, Tourism and Economic Development. Washington, DC; 2006.
  49. DoD Global Emerging Infections System: Annual Report: Partnering in the Fight against Emerging Infections. Washington, DC: U.S. Department of Defense; 2005. http://www.geis.fhp.osd.mil/GEIS/aboutGEIS/annualreports/GEIS_AR_05.pdf. Accessed August 14, 2007.
  50. DoD Global Emerging Infections Surveillance and Response System: Annual Report: Partnering in the Fight against Emerging Infections. Washington, DC: U.S. Department of Defense; 2006. http://www.geis.fhp.osd.mil/GEIS/aboutGEIS/annualreports/GEIS_06_LR.pdf. Accessed August 14, 2007.
  51. Naval Medical Research Center. NAMRU2. Emerging Diseases Research. http://www.nmrc.navy.mil/namru_2_edr.htm Accessed August 14, 2007.
  52. Guiding principles for international outbreak alert and response. WHO website. http://www.who.int/csr/outbreaknetwork/guidingprinciples/en/print.html. Accessed June 5, 2006.
  53. Global Outbreak Alert and Response. Report of a WHO meeting. Geneva: World Health Organization; April 26–28, 2000.
  54. Heymann DL, Aylward RB. Poliomyelitis eradication and pandemic influenza. Lancet 2006 May 6;367(9521):1462–
    1464.
  55. H5N1 avian influenza: timeline of major events. WHO website; July 2007. http://www.who.int/csr/disease/avian_influenza/ai_timeline/en/index.html. Accessed August 14, 2007.
  56. Jamison DT, Breman JG, Measham AR, et al., eds. Disease Control Priorities in Developing Countries. 2nd ed. Washington, DC: Disease Control Priorities Project; 2006.
  57. One World, One Health website. http://www.oneworldonehealth.org/. Accessed April 3, 2006.
  58. Julian KG, Eidson M, Kipp AM, et al. Early season crow mortality as a sentinel for West Nile virus disease in humans, northeastern United States. Vector Borne Zoonotic Dis 2002 Fall;2(3):145–155.
  59. Updated guidelines for evaluating public health surveillance systems: recommendations from the guidelines working group. MMWR Morb Mortal Wkly Rep 2001 Jul 27;50(RR13):1–35.
  60. Pavlin J. Investigation of disease outbreaks detected by “syndromic” surveillance systems. J Urban Health 2003 Jun;80(2 suppl 1):i107–114.
  61. Sokolow LZ, Grady N, Rolka H, et al. Deciphering data anomalies in BioSense. MMWR Morb Mortal Wkly Rep 2005 Aug 26;54 Suppl:133–139.
  62. Wagner MM, Tsui FC, Espino JU, et al. The emerging science of very early detection of disease outbreaks. J Pub Health Mgmt Pract 2001 Nov;7(6):51–59.
  63. Wong WK, Moore A, Cooper G, Wagner M. WSARE: What’s Strange About Recent Events? J Urban Health 2003 Jun;80(2 Suppl 1):i66–75.
  64. Reingold A. If syndromic surveillance is the answer, what is the question? Biosecur Bioterror 2003;1(2):77–81.
  65. Sosin DM. Syndromic surveillance: the case for skillful investment. Biosecur Bioterror 2003;1(4):247–253.
  66. Ferguson NM, Cummings DA, Fraser C, Cajka JC, Cooley PC, Burke DS. Strategies for mitigating an influenza pandemic. Nature 2006 Jul 27;442(7101):448–452.
  67. Veenema TG, T ke J. Early detection and surveillance for biopreparedness and emerging infectious diseases. Online J Issues Nurs 2006 Jan 31;11(1):3.
  68. Mobiles ‘to help track diseases.’ BBC News 17 October 2006. http://news.bbc.co.uk/2/hi/technology/6058162.stm. Accessed August 14, 2007.
  69. Woodall J, Aldis R. Gaps in Global Surveillance. Occasional Papers Number 1. Geneva, Switzerland: BioWeapons Prevention Project; 2003.
  70. Osaka K, Takahashi H, Ohyama T. Testing a symptom-based surveillance system at high-profile gatherings as a preparatory measure for bioterrorism. Epidemiol Infect 2002 Dec;129(3):429–434.
  71. Acute Communicable Disease Control, Special Studies Report 2000. http://www.lapublichealth.org/acd/reports/spclrpts/spcrpt00/
  72. Carrat F, Flahault A, Boussard E, Farran N, Dangoumau L, Valleron AJ. Surveillance of influenza-like illness in France. The example of the 1995/1996 epidemic. J Epidemiol Community Health 1998 Apr;52 Suppl 1:32S–38S.
  73. Fidler DP. International legal considerations for the quarantine station expansion. In: Sivitz LB, Stratton K, Benjamin GC, eds. Quarantine Stations at Ports of Entry, Protecting the Public’s Health. Washington, DC: National Acadamies Press; 2006:199–304.
  74. Ministers of Foreign Affairs of Brazil, France, Indonesia, Norway, Senegal, South Africa, and Thailand. Oslo Ministerial Declaration—Global health: a pressing foreign policy issue of our time. Lancet 2007 Apr 21;369(9570):1373–1378. http://multimedia.thelancet.com/pdf/oslo.pdf. Accessed August 15, 2007.